Cargando…

Unraveling the Interplay between Nonalcoholic Fatty Liver Disease and Polycystic Ovary Syndrome in Adolescents: Pathogenesis, Prevalence, and Management Strategies

BACKGROUND: With the expanding understanding of conditions contributing to heightened cardiovascular risk, emerging pathologies like nonalcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS) are being recognized as hepatic and ovarian manifestations of metabolic syndrome, respect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Półkośnik, Kinga, Łebkowska, Agnieszka, Kowalska, Irina, Lebensztejn, Dariusz M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2023
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360446/ https://www.ncbi.nlm.nih.gov/pubmed/37455412 http://dx.doi.org/10.12659/MSM.940398

Ejemplares similares

Effects of Ketogenic Diet on Reproductive Hormones in Women With Polycystic Ovary Syndrome
por: Khalid, Karniza, et al.
Publicado: (2023)

Mean platelet volume and polycystic ovary syndrome: a systematic review and meta-analysis
por: Li, Li, et al.
Publicado: (2022)

Effects of probiotic and synbiotic supplementation on insulin resistance in women with polycystic ovary syndrome: a meta-analysis
por: Miao, Chenyun, et al.
Publicado: (2021)

The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis
por: Ding, Tao, et al.
Publicado: (2017)

Methylenetetrahydrofolate reductase C677T polymorphism and the risks of polycystic ovary syndrome: an updated meta-analysis of 14 studies
por: Wang, Lihong, et al.
Publicado: (2017)

The Effect of Statins on Levels of Dehydroepiandrosterone (DHEA) in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Yang, Song, et al.
Publicado: (2019)

Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis
por: Tang, Yao, et al.
Publicado: (2019)

Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis
por: Huang, Yi-Zhou, et al.
Publicado: (2021)

Influence of vitamin D supplementation on lipid levels in polycystic ovary syndrome patients: a meta-analysis of randomized controlled trials
por: Jin, Bihui, et al.
Publicado: (2020)

Hepatitis B virus infection and the risk of nonalcoholic fatty liver disease: a meta-analysis
por: Xiong, Jianping, et al.
Publicado: (2017)

Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis
por: Patel, Parita, et al.
Publicado: (2020)

Update on pathogenesis, diagnostics and therapy of nonalcoholic fatty liver disease in children
por: Flisiak-Jackiewicz, Marta, et al.
Publicado: (2019)

Metabolic benefits of changing sedentary lifestyles in nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials
por: Ma, Qianqian, et al.
Publicado: (2022)

Meta-analysis of the efficacy of ω-3 polyunsaturated fatty acids when treating patients with polycystic ovary syndrome
por: Huang, Yue, et al.
Publicado: (2023)

Correlation Between Adiponectin Gene rs1501299 Polymorphism and Nonalcoholic Fatty Liver Disease Susceptibility: A Systematic Review and Meta-Analysis
por: Liu, Jiaxing, et al.
Publicado: (2019)

The Association Between Serum Ferritin Concentration and Visceral Adiposity Estimated by Whole-Body DXA Scan in Women With Polycystic Ovary Syndrome
por: Adamska, Agnieszka, et al.
Publicado: (2020)

Body Composition, Serum Concentrations of Androgens and Insulin Resistance in Different Polycystic Ovary Syndrome Phenotypes
por: Polak, Aleksandra Maria, et al.
Publicado: (2020)

Decreased deiodinase activity after glucose load could lead to atherosclerosis in euthyroid women with polycystic ovary syndrome
por: Adamska, Agnieszka, et al.
Publicado: (2019)

Elevated Serum Concentration of Adipocyte Fatty Acid-Binding Protein Correlates with the Markers of Abdominal Obesity Independently of Thyroid Hormones in Non-Obese Women with Polycystic Ovary Syndrome
por: Polak, Aleksandra Maria, et al.
Publicado: (2023)

Nitric oxide (NO) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis
por: Meng, Chan
Publicado: (2019)

Ovarian Reserve and Serum Concentration of Thyroid Peroxidase Antibodies in Euthyroid Women With Different Polycystic Ovary Syndrome Phenotypes
por: Adamska, Agnieszka, et al.
Publicado: (2020)

Serum Concentrations of Betatrophin and Its Association with Indirect Indices of Insulin Resistance and Beta Cell Function in Women with Polycystic Ovary Syndrome
por: Adamska, Agnieszka, et al.
Publicado: (2017)

Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis
por: Wijarnpreecha, Karn, et al.
Publicado: (2018)

Increased serum fetuin-B concentration is associated with HOMA-β and indices of liver steatosis in women with polycystic ovary syndrome: a pilot study
por: Adamska, Agnieszka, et al.
Publicado: (2019)

A systematic review and future research agenda on detection of polycystic ovary syndrome (PCOS) with computer-aided techniques
por: Suha, Sayma Alam, et al.
Publicado: (2023)

Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)

Relationship between nonalcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome
por: Kara, Ozlem, et al.
Publicado: (2023)

Efficacy and safety of semaglutide in non-alcoholic fatty liver disease
por: Zhu, Kai, et al.
Publicado: (2023)

Outcome of Phlebotomy for Treating Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
por: Jaruvongvanich, Veeravich, et al.
Publicado: (2016)

Association between gastroesophageal reflux disease and nonalcoholic fatty liver disease: A meta-analysis
por: Wijarnpreecha, Karn, et al.
Publicado: (2017)

The Association of Serum Levels of Leptin and Ghrelin with the Dietary Fat Content in Non-Obese Women with Polycystic Ovary Syndrome
por: Polak, Aleksandra Maria, et al.
Publicado: (2020)

Novel glucose-lowering drugs for non-alcoholic fatty liver disease
por: Fu, Zuo-Di, et al.
Publicado: (2021)

Long-chain omega-3 polyunsaturated fatty acids and the risk of heart failure
por: Zheng, Sulin, et al.
Publicado: (2022)

Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis
por: Pan, Lu, et al.
Publicado: (2021)

Statin liver safety in non‐alcoholic fatty liver disease: A systematic review and metanalysis
por: Pastori, Daniele, et al.
Publicado: (2021)

Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome
por: Wang, Dongxu, et al.
Publicado: (2022)

Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: a meta-analysis
por: Hu, Jianping, et al.
Publicado: (2017)

Omega-3 fatty acid supplementation is associated with favorable outcomes in patients with sepsis: an updated meta-analysis
por: Wang, Chenyang, et al.
Publicado: (2020)

Relationship between non-alcoholic fatty liver disease and cardiac arrhythmia: a systematic review and meta-analysis
por: Gong, Hang, et al.
Publicado: (2021)

Meta-analysis reveals up-regulation of cholesterol processes in non-alcoholic and down-regulation in alcoholic fatty liver disease
por: Wruck, Wasco, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7qv59ini6q93aqac1k2d8kdfgm